Regulatory T cells (T reg cells), which have abundant expression of the interleukin 2 receptor (IL-2R), are reliant on IL-2 produced by activated T cells. This feature indicates a key role for a simple network based on the consumption of IL-2 by T reg cells in their suppressor function. However, congenital deficiency in IL-2R results in reduced expression of the T reg cell lineage-specification factor Foxp3, which has confounded experimental efforts to understand the role of IL-2R expression and signaling in the suppressor function of T reg cells. Using genetic gain-and loss-of-function approaches, we found that capture of IL-2 was dispensable for the control of CD4 + T cells but was important for limiting the activation of CD8 + T cells, and that IL-2R-dependent activation of the transcription factor STAT5 had an essential role in the suppressor function of T reg cells separable from signaling via the T cell antigen receptor.
Regulatory T cells (T reg cells) that express the transcription factor
Foxp3 restrain immune responses to self and foreign antigens [1] [2] [3] . T reg cells have abundant expression of the interleukin 2 receptor α-chain (IL-2Rα; CD25) but are unable to produce IL-2. IL-2 binds with low affinity to IL-2Rα or to heterodimers of the common γ-chain (γ c ; CD132) and IL-2Rβ (CD122), but receptor affinity increases ~1,000-fold when these three subunits collectively interact with IL-2 (ref. 4) . IL-2 and the transcription factor STAT5, a key target downstream of JAK kinases associated with IL-2R, are indispensable for inducing the expression of Foxp3 and differentiation of T reg cells in the thymus [5] [6] [7] [8] [9] [10] [11] . IL-2Rβ and γ c are shared with the IL-15 receptor, whose signaling can also contribute to the induction of Foxp3 expression 12 . IL-2, in cooperation with the cytokine TGF-β, is also required for extrathymic T reg cell differentiation 13 .
While the role of IL-2R signaling in the induction of Foxp3 expression and T reg cell differentiation in the thymus is well established, the importance of IL-2R expression in mature T reg cells is not well understood. Although deficiency in STAT5 abolishes Foxp3 expression, it can be restored by increased amounts of the anti-apoptotic molecule Bcl2. That finding raised the possibility that a chief role of IL-2 might be in the survival of differentiating T reg cells or their precursors 14 . It has also been reported that ablation of the pro-apoptotic protein Bim can rescue T reg cells or their precursors from apoptosis associated with deficiency in IL-2 or IL-2R and restore the number of T reg cells, but it does not prevent fatal autoimmunity 15 . However, a profound effect of congenital deficiency in IL-2, Bcl2 and Bim on the differentiation and selection of T reg cells and self-reactive effector T cells (T eff cells) has confounded interpretation of that observation. Antibody-mediated neutralization of IL-2 in adult mice that have undergone removal of the thymus reduces the number of T reg cells and Foxp3 expression in T reg cells 16, 17 . Thus, IL-2 supports stability of the T reg cell lineage after differentiation 18, 19 . However, expression of a transgene encoding IL-2Rβ exclusively in thymocytes has been reported to rescue Il2rb −/− mice from lethal autoimmune disease, which suggests that IL-2R expression is dispensable in peripheral T reg cells 7, 11 . Thus, a role for IL-2R expression and signaling in peripheral T reg cells has remained uncertain. Hypothetically, a role for IL-2R in peripheral T reg cells could be threefold: guidance for T reg cells to sense their targets, which are activated self-reactive T cells that serve as a source of IL-2; T reg cell-mediated deprivation of IL-2 as a mechanism of suppression; and cell-intrinsic IL-2 signaling in differentiated T reg cells to support their maintenance, proliferation or function due to triggering of JAK-STAT5, PI3K-Akt or Ras-ERK signaling pathways. Previous studies have focused mainly on the induction or maintenance of Foxp3, while other aspects of IL-2R function have not been firmly established due to the aforementioned limitations.
Despite their considerable reliance on IL-2 for the maintenance of Foxp3 expression, T reg cells are unable to produce IL-2. The reason for the inhibition of autologous activation of STAT5 in T reg cells and the potential biological importance of this IL-2-based T reg cell-T eff cell regulatory loop also remain unknown. It has been suggested that repression of IL-2 is needed to maintain the 'unbound' state of high-affinity IL-2R on T reg cells, and unbound IL-2R serves a key role in T reg cell-mediated suppression by depriving T eff cells of ; however, whether this mechanism has a non-redundant role in suppression in vivo is unknown. To address the role of IL-2R and downstream signaling pathways in differentiated T reg cells, we ablated IL-2Rα, IL-2Rβ and STAT5 in Foxp3-expressing cells. By simultaneously inducing expression of an active form of STAT5, we assessed the differential requirements for IL-2R expression and IL-2 signaling in T reg cell homeostasis versus T reg cell suppressor activity.
RESULTS

IL-2R is indispensable for T reg cell function
To definitively establish a role for IL-2R in T reg cell function in vivo, we generated mice with T reg cell-specific conditional knockout of IL-2Rβ by using Cre recombinase driven by the endogenous Foxp3 locus (Foxp3 Cre ) to delete loxP-flanked Il2rb alleles (Il2rb fl/fl ) in T reg cells after Foxp3 was expressed. Il2rb fl/fl Foxp3 Cre mice developed systemic fatal autoimmune inflammatory lesions and lymphoproliferation, albeit somewhat milder than that observed in mice with germline Foxp3 deficiency 3 (Fig. 1a-c) . The expression of IL-2Rβ and IL-2Rα was lower in Il2rb fl/fl Foxp3 Cre peripheral T reg cells than in their Il2rb fl/wt Foxp3 Cre counterparts (Fig. 1d) , and tyrosine-phosphorylation of STAT5 in response to IL-2 was lacking in Il2rb fl/fl Foxp3 Cre peripheral T reg cells (Fig. 1e) . The frequency of Foxp3 + cells among CD4 + T cells and the expression of Foxp3 on a per-cell basis were both lower in Il2rb fl/fl Foxp3 Cre mice than in Il2rb fl/wt Foxp3 Cre mice (Fig. 1f) . In healthy Il2rb fl/fl Foxp3 Cre/wt female mice, in which IL-2Rβ-sufficient T reg cells and IL-2Rβ-deficient T reg cells co-exist due to random inactivation of the X chromosome, IL-2Rβ-deficient T reg cells were under-represented (Fig. 1g,h ). It has been suggested that IL-2 is selectively required for the maintenance of CD62L hi CD44 lo T reg cells but is dispensable for CD62L lo CD44 hi T reg cells 25 . However, we found that the abundance of both CD62L hi CD44 lo T reg cells and CD62L lo CD44 hi T reg cells was significantly lower in the absence of IL-2Rβ than in its presence in healthy Il2rb fl/fl Foxp3 Cre/wt female mice (Supplementary Fig. 1a ). In these mice, IL-2Rβ-deficient (Il2rb fl/fl Foxp3 Cre/wt ) T reg cells had lower expression of Foxp3 and the T reg cell 'signature' molecules IL-2Rα, CTLA-4, GITR and CD103 than that of IL-2Rβ-sufficient (Il2rb fl/wt Foxp3 Cre/wt ) T reg cells regardless of their expression of CD62L and CD44 (Fig. 1i,j and Supplementary  Fig. 1a) . Although in diseased Il2rb fl/fl Foxp3 Cre mice, the majority of T reg cells were CD62L lo CD44 hi , this was probably a consequence of severe inflammation, because the frequency of T reg cells was also much lower in Il2rb fl/fl Foxp3 Cre mice than in Il2rb fl/wt Foxp3 Cre mice at sites at which CD62L lo CD44 hi cells were prevalent-i.e., the small and large intestines (Supplementary Fig. 1b) . Accordingly, the expression of many characteristic T reg cell markers, except for CD25 and Foxp3, was upregulated as the result of T reg cell activation in Il2rb fl/fl Foxp3 Cre mice (Supplementary Fig. 1c ). These observations suggested that both the CD62L hi CD44 lo T reg cell subset and the CD62L lo CD44 hi T reg cell subset, including those residing in nonlymphoid tissues, were dependent on IL-2, although under inflammatory conditions the latter was sustained to some extent by IL-2R-independent signals. Despite their upregulation of the expression of CTLA-4, GITR, the costimulatory receptor ICOS and CD103, the 'activated' IL-2Rβ-deficient T reg cells from Il2rb fl/fl Foxp3 Cre mice were still unable to control inflammation in the diseased mice and were not suppressive when transferred together with T eff cells into lymphopenic recipients (data not shown).
Our findings raised the question whether ablation of IL-2Rα (which, in addition to facilitating IL-2 signaling, enables its sequestration from T eff cells) would result in T reg cell deficiency and disease similar to that of Il2rb fl/fl Foxp3 Cre mice. Thus, we generated mice with a loxP-flanked Il2ra allele (J.D.F., data not shown) and induced its conditional ablation in T reg cells by means similar to those described above. We found that T reg cell-specific deficiency in IL-2Rα resulted in a disease with an early onset and severity similar to that observed after ablation of IL-2Rβ (Supplementary Fig. 1d-f) . Of note, germline deficiency in either Il2ra or Il2rb in mice on the same C57BL6/J strain as that of our mice with conditional knockout resulted in a considerably less aggressive disease with a delayed onset (data not shown), probably due to the role of IL-2R signaling in T eff cells. Our findings also indicated that IL-15 was unable to effectively compensate for the loss of IL-2 signaling in differentiated T reg cells, because in Il2ra fl/fl Foxp3 Cre mice, T reg cells lacked only signaling via IL-2, whereas in Il2rb fl/fl Foxp3 Cre mice, they lacked signaling via both IL-2 and IL-15, yet they were affected similarly. This was in contrast to T reg cell differentiation in the thymus, in which IL-15 can contribute in part to Foxp3 induction 12 .
Since IL-2R activates PI3K-Akt, MAPK, and JAK-STAT5 signaling pathways, we next sought to assess the role of STAT5 activation downstream of IL-2R signaling in T reg cells. We found that ablation of STAT5 impaired T reg cell function similarly to ablation of IL-2Rβ and that Stat5a fl/fl Stat5b fl/fl Foxp3 Cre mice were affected by fatal autoimmunity in a way similar to that of mice harboring IL-2R-deficient T reg cells (Supplementary Fig. 1g-k) . Thus, in agreement with IL-2-neutralization studies, these results indicated that IL-2R signaling was required for T reg cell fitness in a cell-intrinsic manner.
Restoring STAT5 signaling in IL-2R-deficient T reg cells The findings reported above indicated that activation of STAT5 downstream of IL-2R was continuously required for T reg cell function. However, the marked decrease in IL-2R expression observed in STAT5-deficient T reg cells (Supplementary Fig. 1g ) made it impossible to separate loss of STAT5 from impairment in all IL-2R functions (i.e., detection of IL-2, transduction of STAT5-dependent and STAT5-independent signals, and consumption and deprivation of IL-2) as a key contributor to the observed severe dysfunction of T reg cells.
To address that major caveat and to understand the role of STAT5 versus that of IL-2R, we sought to determine whether expression of a gain-of-function form of STAT5b was able to restore T reg cell function in the absence of IL-2R. A published study using a transgene encoding a constitutively active form of STAT5b (STAT5b-CA) driven by the proximal promoter of the gene encoding the kinase Lck in the absence of IL-2Rβ showed restoration of T reg cell differentiation in the thymus but not rescue from lymphoproliferative syndrome 9 . However, the expression of this transgene early during thymopoiesis leads to leukemic lymphoproliferation, which complicated the interpretation of those findings. In addition, both the activity of the proximal Lck promoter and the expression of the transgene became lower over time in peripheral T cells in these mice 9 . Therefore, we generated a gene-targeted mouse strain using the Rosa26 'gene-trap' locus 26 in which a transgene encoding STAT5b-CA driven by a CAG promoter (chicken β-actin promoter with cytomegalovirus enhancers) 27 is preceded by a loxP-flanked STOP cassette (Supplementary Fig. 2a ). In the resulting Rosa26 Stat5bCA mice, STAT5b-CA is expressed only when the loxP sites undergo Cre-mediated recombination. Introduction of the Rosa26 Stat5bCA allele into Il2rb fl/fl Foxp3 Cre mice and the consequent expression of STAT5b-CA in IL-2Rβ-deficient T reg cells rescued the mice from the systemic inflammation and early fatal disease (Supplementary Fig. 2b ). In these mice, the frequency and 1 3 2 4 VOLUME 17 NUMBER 11 NOVEMBER 2016 nature immunology A r t i c l e s number of T reg cells were comparable to or even surpassed those in IL-2R-sufficient Il2rb wt/wt Foxp3 Cre mice (Fig. 2a) . Notably, the expression of IL-2Rα was higher in T reg cells from Rosa26 Stat5bCA Il2rb fl/fl Foxp3 Cre mice than in those from Il2rb fl/fl Foxp3 Cre or Il2rb wt/wt Foxp3 Cre mice, despite the absence of the IL-2Rβ chain (Fig. 2a) , which suggested that the expression of IL-2Rα on T reg cells was controlled mainly by STAT5-dependent signaling but not by STAT5-independent signaling. Notably, these IL-2Rβ-deficient T reg cells with heightened IL-2Rα expression remained unresponsive to IL-2 (Fig. 2b) .
The observed restoration of the suppressor function of IL-2Rβ-deficient T reg cells and rescue from the early fatal disease via expression of STAT5b-CA raised the possibility that the reintroduced high levels of IL-2Rα were responsible for these effects. However, expression of STAT5b-CA similarly rescued Il2ra fl/fl Foxp3 Cre mice from the early fatal disease (Supplementary Fig. 2c-h) . Notably, although the impaired ability of T reg cells to capture and consume IL-2 in both Il2rb fl/fl Foxp3 Cre mice and Il2ra fl/fl Foxp3 Cre mice was not 'rescued' via expression of STAT5b-CA (Fig. 2c) , the reactivity of CD4 + T cells was Cre/wt 0 10 
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Cre/wt fully controlled in these mice ( Fig. 2d and Supplementary Fig. 2d-h ). These results suggested that the ability to capture and compete for IL-2 was dispensable for T reg cell-mediated suppression of CD4 + T cell responses. In contrast, however, the population expansion of CD8 + T cells, in particular that of activated CD62L hi CD44 hi CD8 + T cells, was restrained only marginally in these mice ( Fig. 2d and Supplementary  Fig. 2f,h ). Although expansion of the CD8 + CD62L lo CD44 hi subset was relatively well controlled, albeit not perfectly controlled, in neonatal mice ( Fig. 2d and Supplementary Fig. 2f ), this subset also gradually started to expand in these mice as early as 3 weeks after birth ( Supplementary Fig. 2i ). Fig. 2i,j) . These findings raised the possibility that IL-2 consumption by T reg cells, while dispensable for the control of CD4 + T cells, was important for the restraint of CD8 + T cells. Fig. 2e and Supplementary Fig. 3a) .
In Il2rb fl/fl Foxp3 Cre mice, which spontaneously developed disease, production of the T H 2 (T helper type 2) cytokines IL-4 and IL-13 by CD4 + T cells was significantly reduced by neutralization of IL-2; however, the activation of CD4 + and CD8 + T cells was at best reduced only marginally or unaffected. In contrast, the activation and proliferation of CD8 + T cells observed in Rosa26 Stat5bCA Il2rb fl/fl Foxp3 Cre mice was almost completely suppressed by this treatment.
The relative reduction in the CD8 + CD62L lo CD44 hi T cell subset and more pronounced proliferation of CD8 + CD62L hi CD44 hi T cell subset in Rosa26 Stat5bCA Il2rb fl/fl Foxp3 Cre and Rosa26 Stat5bCA Il2ra fl/fl Foxp3 Cre mice raised the possibility that loss of IL-2-consumption by T reg cells might selectively impair their suppression of the population expansion of memory CD8 + T cells but not the recruitment of naive CD8 + T cells into the effector-cell pool. We tested this idea by adoptive transfer of CD4 + and CD8 + cell subsets into lymphopenic recipients. Consistent with observations of Foxp3 Cre mice, the impaired suppression of the population expansion and activation of CD4 + T cells by IL-2R-deficient T reg cells was completely 'rescued' by STAT5b-CA; in contrast, their ability to suppress memory CD8 + T cells was not restored, whereas suppression of the population expansion and activation of naive CD8 + T cells was recovered only partially (Fig. 2f) . Thus, IL-2 consumption by T reg cells seemed to have a nonredundant role in suppressing the population expansion and activation of both the naive CD8 + T cell subset and memory CD8 + T cell subset, although this mechanism seemed to be particularly prominent in control of the latter subset.
Although the majority of activated CD8 + T cells in Il2rb fl/fl Foxp3 Cre and Rosa26 Stat5bCA Il2rb fl/fl Foxp3 Cre mice did not have detectable expression of IL-2Rα (Supplementary Fig. 3a) , these cells were able to activate STAT5 in response to IL-2, albeit to a lesser extent than that observed in cells expressing IL-2Rα (Supplementary Fig. 3b) . A small proportion of activated CD4 + T cells with undetectable IL-2Rα expression also responded to IL-2, but the majority of them did not (Supplementary Fig. 3b ). naive T CD8 + cells also responded to IL-2, while naive CD4 + T cells did not (Supplementary Fig. 3b) . Thus, both naive CD8 + T cells and activated CD8 + T cells seemed to be more sensitive to IL-2 than were CD4 + T cells, and IL-2 consumption by T reg cells might have markedly affected their activation. A corollary to that idea was that activation of STAT5 in CD8 + T cells but not in CD4 + T cells might render the former resistant to T reg cell-mediated suppression. Thus, we tested the effect of STAT5 activation on the proliferation of CD4 + or CD8 + T cells in the presence of T reg cells. For this purpose, we sorted CD4 + Foxp3 − and CD8 + Foxp3 − T cells from Rosa26 Stat5bCA Foxp3 Cre mice and induced expression of STAT5b-CA in these cells by treating them with recombinant Cre protein containing a membrane-permeable TAT peptide (trans-activating transcriptional activator from human immunodeficiency virus) (TATCre). We adoptively transferred the treated cells into lymphopenic recipients with or without T reg cells. Although treatment with TATCre initially induced STAT5b-CA expression in approximately 30% of the treated CD4 + T cells and CD8 + T cells, more than 95% of CD8 + T cells expressed STAT5b-CA 3 weeks after the cell transfer, whereas STAT5b-CA expressing CD4 + T cells increased their frequency to only 40-50% (Fig. 2g) . Notably, STAT5b-CA + CD8 + T cell populations robustly expanded in the presence of either control (Il2ra wt/wt Foxp3 Cre ) T reg cells or STAT5b-CA + T reg cells (Fig. 2g,h) . Although some degree of suppression of STAT5b-CA + CD8 + T cells by T reg cells was still observed, it was very mild compared with the suppression of STAT5b-CA − CD8 + T cells (Fig. 2h) . In contrast, the proliferation and cytokine production of activated CD4 + T cells, regardless of the expression of STAT5b-CA, were well controlled by T reg cells (Fig. 2h) . These observations suggested that STAT5 activation in CD8 + T cells prompted robust population expansion of cells and conferred pronounced resistance to T reg cell-mediated suppression, but STAT5 activation in CD4 + T cells did not. Consistent with those findings, gain-of-function experiments in which IL-2 was provided in the form of immunocomplexes of IL-2 and antibody to IL-2 showed population expansion of CD8 + T cells and CD4 + T reg cells but not of CD4 + T eff cells 28 . Thus, while the ability to capture and compete for IL-2 was dispensable for T reg cell-mediated suppression of CD4 + T cell responses, this mode of suppression appeared to be essential for the control of CD8 + T cells, which responded to excessive IL-2 more robustly than did CD4 + T cells.
STAT5 activation in T reg cells boosts immunosuppression
The lack of detectable STAT5 activation in response to IL-2 and of STAT5b-CA-driven population expansion of IL-2R-sufficient T reg cells that escaped Cre-mediated recombination (counter-selection) in both Rosa26 Stat5bCA Il2rb fl/fl Foxp3 Cre mice and Rosa26 Stat5bCA Il2ra fl/ fl Foxp3 Cre mice indicated that the expression of an active form of STAT5 relieved T reg cells from their dependence on IL-2 signaling. This finding offered a unique opportunity to explore the biological importance of the aforementioned IL-2-dependent T reg cell-T eff cell regulatory network by uncoupling T reg cell function from IL-2 production by T eff cells. To address this issue, we generated Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice, with tamoxifen-inducible expression of STAT5b-CA in differentiated T reg cells (via the tamoxifen-sensitive estrogen receptor variant ERT2) 17 . Induction of STAT5b-CA expression in ~20-30% of T reg cells by a single administration of tamoxifen was followed by their rapid increase in number at the expense of T reg cells with a non-recombined Rosa26 Stat5bCA allele (Supplementary Fig. 4a,b) . It was notable that these cells exhibited a highly diverse use of the T cell antigen receptor (TCR) β-chain variable region similar to that in Rosa26 wt Foxp3 Cre-ERT2 (control) mice (Supplementary Fig. 4c ). The experimental Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice remained healthy ( Supplementary  Fig. 4d,e) . In these mice, the proliferated STAT5b-CA + T reg cell population had larger amounts of Foxp3, CD25, CTLA-4 and GITR than those in STAT5b-CA − T reg cells in tamoxifen-treated Rosa26 wt Foxp3 Cre-ERT2 mice and had a higher proportion of CD62L hi CD44 hi cells than CD62L hi CD44 lo cells (Fig. 3a-d and Supplementary Fig. 4f) , indicative of a STAT5b-CA-imposed biasing of the T reg cell population toward an activated state or a memory state. Consistent with those possibilities, surface expression of IL-7R, the activation marker KLRG1 and CD103 was higher in STAT5b-CA + T reg cells in tamoxifen-treated Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice than in STAT5b-CA − T reg cells in tamoxifen-treated Rosa26 wt Foxp3 Cre-ERT2 mice (Fig. 3d) . Notably, in the LNs and Peyer's patches, the number of T reg cells did not increase after the administration of tamoxifen, despite the predominance of STAT5b-CA + T reg cells in the former mice ( Supplementary Fig. 4b,g ); this suggested that T reg cells with activated STAT5 'preferentially' distributed in non-lymphoid tissues. The abundance of CD8 + Foxp3 + cells also increased after the induction of STAT5b-CA (Supplementary Fig. 4h) . The 'autonomous' T reg cells expressing active STAT5 showed heightened in vitro suppressor activity (Supplementary Fig. 4i ) and effectively suppressed the basal state of activation and proliferative activity of CD4 + and CD8 + T cells in vivo as well, as indicated by the decreased number of Ki67 + cells and CD62L lo CD44 hi T eff cells and much larger CD62L hi CD44 lo naive T cell pool ( Fig. 3e and Supplementary Fig. 5a,b) . Accordingly, the production of pro-inflammatory cytokines, most prominently IL-4, by CD4 + T cells and expression of the costimulatory molecules CD80 and CD86 by B cells and dendritic cells (DCs) were reduced after the administration of tamoxifen (Fig. 3f and Supplementary  Fig. 5c ). These results indicated that expression of STAT5b-CA conferred enhanced suppressor function to T reg cells.
T reg cells have been proposed to promote systemic responses of the T H 17 subset of helper T cells and class switching to immunoglobulin A (IgA) in the gut 29, 30 . However, we found that serum and fecal IgA as well as T H 17 responses in secondary lymphoid organs were diminished rather than being increased in the presence of STAT5b-CA + T reg cells (Fig. 3g and Supplementary Fig. 5c ). Serum IgM and IgE also showed a tendency toward a decrease, but this was not statistically significant ( Supplementary Fig. 5d ). These results were in agreement with the increase in T H 17 responses and in both T H 2-type immunoglobulin class switching and T H 1-type immunoglobulin class switching observed upon acute ablation of T reg cells 31 .
Since altered intestinal immune responses have been linked to the promotion of colonic carcinogenesis, we explored an effect of a gain in T reg cell suppressor function afforded by activated STAT5 in the Apc Min model of colorectal cancer. Mice harboring the Apc Min mutation develop multiple adenomatous polyps in the small intestine 32 . Apc Min Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice developed a number of polyps similar to or fewer than that of Apc Min Foxp3 Cre-ERT2 mice, but the average polyp size was greater in Apc Min Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice than in Apc Min Foxp3 Cre-ERT2 mice (Supplementary Fig. 5e ). These results were consistent with the idea that suppression of inflammation by T reg cells in tumor microenvironments promotes the growth of tumors once tumors or pre-cancerous lesions are already formed. However, the early stages of colonic carcinogenesis seemed to be not promoted but potentially suppressed by T reg cells with augmented suppressor activity.
In addition to restraining the basal immunological reactivity in physiological settings and modulating colon-carcinoma development, 'autonomous' T reg cells afforded superior protection against autoantigen-induced autoimmunity. We found that at 2-3 months after a single tamoxifen treatment, Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice were very resistant to experimental autoimmune encephalomyelitis 
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induced by immunization with myelin oligodendrocyte glycoprotein peptide in complete Freund's adjuvant (Fig. 4a-c) . The frequency of CD4 + Foxp3 + cells was significantly greater in the brain and spinal cord of these mice (Fig. 4b) , and the infiltration of inflammatory cells, including neutrophils and IL-17-producing CD4 + T H 17 cells, into these organs was significantly lower (Fig. 4c) than that of Foxp3 Cre-ERT2 mice. Pathogen-specific responses were also diminished in Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice relative to those in Foxp3 Cre-ERT2 mice (also at 2-3 months after a single tamoxifen treatment). Although Listeria-monocytogenes-specific T H 1 responses were suppressed only modestly (Fig. 4d) , vaccinia-virus-specific CD8 + T cell responses were markedly reduced in the presence of STAT5b-CA + T reg cells (Fig. 4e) . Our observation of diminished responses to infectious agents and modulation of cancer progression might provide a rationale for why T reg cells lack IL-2 production and autonomous activation of STAT5 and instead are reliant on activated T cells as a source of IL-2.
A distinct role for STAT5 activation in T reg cells Next we sought to address the question of how sustained STAT5 signaling might potentiate T reg cells' suppressive ability. In genetic loss-and gain-of-function studies, STAT5 activity in T reg cells correlated with their proliferative capacity and expression of IL-2Rα and Foxp3. However, the in vitro suppression assays reported above, as well as the diminished activation of the immune system in the LNs and Peyer's patches of Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice, in which fewer T reg cells were found than in Foxp3 Cre-ERT2 mice, suggested that the enhanced immunosuppression observed in Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice was not simply due to a numerical increase of T reg cells but that their suppressor activity on a per-cell basis was also augmented. It was also unlikely that mild upregulation of Foxp3 expression in the presence of STAT5b-CA could account for the increased suppressor activity of T reg cells, as genome-wide binding of Foxp3 does not change after T reg cells are activated, which leads to an increase in Foxp3 expression more pronounced than the one caused by STAT5b-CA 33 . The greater abundance of Foxp3 protein in STAT5b-CA + T reg cells than in STAT5b-CA − T reg cells was particularly noticeable in the CD25 lo T reg cell subset (average difference in mean fluorescence intensity of Foxp3 in Foxp3 + T reg cells from Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice versus that in those from Foxp3 Cre-ERT2 mice (n = 6): CD25 hi cells, 1.06-fold; CD25 lo cells, 1.36-fold; Fig. 3b) , consistent with the observation that STAT5b-CA + T reg cells were relieved from their dependence on IL-2. Nevertheless, STAT5b-CA + T reg cells exhibited more potent suppressor function than that of CD25 hi Foxp3 hi T reg cells from Rosa26 wt Foxp3 Cre-ERT2 (control) mice when transferred together with T eff cells into lymphopenic recipients, despite comparably high expression of Foxp3 (data not shown). Thus, the enhanced suppressor activity of STAT5b-CA + T reg cells was probably not due to the increase in Foxp3.
To gain insight into the potential mechanisms underlying the heightened suppressor function conferred by sustained activation of STAT5, we sorted mature T reg cells from Foxp3 Cre-ERT2 and Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice with comparable expression of Foxp3 and analyzed gene expression in these cells by high-throughput npg sequencing technologies for cDNA (RNA-seq). While the geneexpression profiles of naive CD4 + T cells from both groups of mice were nearly identical, gene expression in T reg cells was markedly affected by the active form of STAT5 (Fig. 5a and Supplementary  Fig. 6a ). Among all genes expressed (~11,000) in either the T reg cell populations or naive CD4 + T cell populations analyzed, 342 genes Table 1) ; line thickness and color are proportional to the similarity coefficient between connected nodes; node color is proportional to the FDR-adjusted P value of the enrichment and node size is proportional to gene-set size.
A r t i c l e s were upregulated and 314 genes were downregulated in STAT5b-CA + T reg cells relative to their expression in STAT5b-CA − T reg cells (Fig. 5b  and Supplementary Fig. 6b) . The gene set upregulated in STAT5b-CA + T reg cells encoded various cell-surface molecules and receptors involved in cell adhesion, migration and cytoskeletal reorganization (Fig. 5c) . Several genes that were upregulated or downregulated in STAT5b-CA − T reg cells relative to their expression in naive T cells showed an opposite trend in STAT5b-CA + T reg cells (Fig. 5c) , which suggested that STAT5b-CA did not simply reinforce the T reg cell signature. A published study has shown that exposure of T reg cells to inflammation induced by transient depletion of T reg cells leads to a marked change in their gene expression and a potent increase in their suppressor function 33 . Consistent with the heightened suppressor function of STAT5b-CA + T reg cells, we found that the gene-expression changes in these cells conferred by the active form of STAT5 correlated with those found in highly activated T reg cells in inflammatory settings (Fig. 5d) . TCR signaling is required for the ability of T reg cells to exert their suppressor function 34, 35 . Thus, it was possible that the TCR-and STAT5-dependent signaling pathways in T reg cells were acting on a largely overlapping set of genes whose expression they jointly regulated to potentiate the suppressor activity of T reg cells. However, our analysis revealed that the gene set affected by the 
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Cre-ERT2 * * ** *** ** ** *** *** *** ** ** * * *** npg active form of STAT5 was distinct from that expressed in T reg cells in a TCR-dependent manner (Fig. 5d) . Thus, both the TCR signaling pathway and STAT5 signaling pathway served an indispensable role in the suppressor activity of T reg cells in vivo by controlling largely distinct sets of genes and probably distinct aspects of T reg cell suppressor activity.
To better understand aspects of T reg cell function potentiated by activation of STAT5, we performed analysis of signaling pathways and molecular-function enrichment. This revealed over-representation of gene sets encoding products involved in cell-cell and extracellular matrix interactions, cell adhesion and cellular locomotion among genes expressed differentially in STAT5b-CA + T reg cells relative to their expression in STAT5b-CA − T reg cells (Fig. 5e,f and Supplementary  Fig. 6c ). This result suggested that in T reg cells, activation of STAT5 might potentiate their interactions with the target cells.
Since intravital imaging of T reg cells in vivo has revealed their stable interactions with DCs 36 , we assessed the potential effect of constitutively active STAT5 in T reg cells on their ability to form conjugates with DCs in vitro. In agreement with the gene-set-enrichment analysis, we found that STAT5b-CA expression in T reg cells promoted the formation of conjugates of T reg cells and DCs (Fig. 6a) . These enhanced interactions of STAT5b-CA + T reg cells with DCs in vitro were consistent with the decreased expression of co-stimulatory molecules by DCs observed in tamoxifen-treated Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice (Fig. 3f) .
The findings reported above raised the question of whether activation of STAT5 can potentiate the suppressor function of T reg cells in a TCR-independent manner. To investigate this, we analyzed Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice with a Tcra fl allele. Tamoxifeninducible Cre-mediated ablation of Tcra (and thus the TCR) in T reg cells is highly efficient in these mice and results in activation of the immune system that results from impaired suppressor function 34 . In heterozygous Tcra fl/wt Foxp3 Cre-ERT2 mice, Cre-mediated recombination can theoretically result in ablation of the TCR in up to a half of T reg cells due to allelic exclusion at the Tcra locus. We observed a small proportion of TCR-deficient T reg cells in these mice after 2 weeks of tamoxifen administration (Fig. 6b) . Although expression of the active form of STAT5 was observed in ~50% of TCR-sufficient and TCR-deficient T reg cells in Tcra fl/wt Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice, the proportion of only TCR-sufficient STAT5b-CA + T reg cells, not TCR-deficient STAT5b-CA + T reg cells, was greater in these mice than in Tcra fl/wt Foxp3 Cre-ERT2 mice (Fig. 6b) . The marked increase in T cell activation and pro-inflammatory cytokine production was mitigated in part by expression of the active form of STAT5 in tamoxifentreated Tcra fl/fl Rosa26 Stat5bCA Foxp3 Cre-ERT2 mice (Fig. 6c) . This partial recovery of T reg cell suppressor function by the active form of STAT5 in T reg cells that had undergone ablation of the TCR was also confirmed in experiments in which flow-cytometry-sorted TCR-deficient STAT5b-CA + T reg cells and T eff cells were adoptively transferred into lymphopenic recipients (Fig. 6d) . Although the 'rescue' was incomplete, these results suggested that enhanced STAT5 signaling potentiated the suppressor activity of T reg cells in the absence of contemporaneous TCR-dependent signals. Indeed, some features of T reg cells that had been observed in TCR-sufficient STAT5b-CA + T reg cells were still present in STAT5b-CA + T reg cells that had undergone TCR ablation (Fig. 6c,d) . However, we note that STAT5b-CA expression failed to restore suppressor function in Tcra fl/fl Rosa26 Stat5bCA Foxp3 Cre mice in which TCR deletion occurred immediately after the induction of Foxp3 (data not shown). It has been shown that TCR signaling is required for the acquisition of an activated, antigen-experienced phenotype and suppressor function by T reg cells 34 . Thus, our results suggested that activation of STAT5 potentiated TCR-independent suppressor function in mature T reg cells that had already undergone TCR-dependent maturation. That observation is reminiscent of the sequential requirement for these two signals, via the TCR and IL-2R, in the differentiation of T reg cells in the thymus, where STAT5 signaling promotes differentiation of T reg cell precursors that have experienced permissive TCR signaling 37 .
DISCUSSION
Published analysis of mice with germline deficiency in IL-2 and IL-2R subunits have demonstrated that IL-2 is a key cytokine required for the induction of Foxp3 expression and the differentiation of T reg cells in the thymus [5] [6] [7] [8] [9] [10] [11] . Furthermore, antibody-mediated neutralization of IL-2 and provision of IL-2 in the form of immunocomplexes of IL-2 and antibody to IL-2, as well as genetic delineation of regulatory elements within the Foxp3 locus, have revealed an important role for IL-2 in the maintenance of mature T reg cells and in the stabilization of Foxp3 expression during their extrathymic differentiation 16, 28, 38 . Such findings have raised the question of whether IL-2R signaling can also directly promote the suppressor ability of T reg cells and can therefore serve as a critical nexus linking the differentiation and maintenance of T reg cells with their suppressor function. A published in vitro study has proposed a role for IL-2 signaling on the basis of indirect evidence 21 . In addition, consumption of IL-2 by T reg cells has been suggested to serve an essential role in the suppressor function of T reg cells by causing the death of activated CD4 + T cells due to IL-2 deprivation [20] [21] [22] [23] [24] . On the other hand, other reports have suggested that IL-2R is dispensable for the ability of T reg cells to suppress the proliferation of effector T cells 8, 39 . Furthermore, the rescue of Il2ra −/− and Il2rb −/− mice from disease observed after adoptive transfer of wild-type T reg cells suggested the existence of major mechanisms of T reg cell-mediated suppression that are independent of IL-2-deprivation 6, 7 . However, the last studies left open the major question of whether IL-2 consumption by T reg cells is essential for the suppression of IL-2R-sufficient T eff cells, since IL-2 is probably a main driver of autoimmune disease in the absence of functional T reg cells.
A chief limiting factor in efforts to experimentally assess a role for IL-2R signaling in and IL-2 consumption by T reg cells in their function in vivo has been the lack of adequate genetic tools. We addressed this issue through the conditional deletion of Il2ra and Il2rb alleles and ablation of the expression of these genes in T reg cells in combination with induced expression of an active form of STAT5. These new genetic tools enabled us to unequivocally demonstrate a cell-intrinsic, essential role for IL-2R signaling not only in the maintenance of mature T reg cells and their fitness but also in their suppressor function. Furthermore, we found that STAT5 deficiency in T reg cells resulted in a similar loss of suppressor function and that expression of an active form of STAT5 rescued mice from the fatal disease that results from IL-2R deficiency. These results suggested a key role for IL-2R-STAT5 signaling in linking the differentiation and maintenance of T reg cells and their function. STAT5 binds to the Foxp3 promoter and the intronic Foxp3 regulatory element CNS2 and is involved in the induction and maintenance of Foxp3 expression 38 . Complexes of the transcription factors Runx and CBFβ also bind to CNS2 and the Foxp3 promoter and affect Foxp3 expression 40 . Although both CNS2-deficient T reg cells and CBFβ-deficient T reg cells do exhibit reduced Foxp3 expression resembling that of STAT5-or IL-2R-deficient T reg cells, the impairment of suppressor function in the last is much more severe. Thus, the decrease in Foxp3 expression alone could not account for the severe loss of T reg cell suppressor function in the absence of STAT5 or IL-2R. Indeed, our analysis of A r t i c l e s gene expression and functional features conferred by expression of the active form of STAT5 pointed to a heightened ability of T reg cells to bind to DCs and suppress their activation. Furthermore, expression of an active form of STAT5 partially 'rescues' the nearly complete loss of T reg cell suppressor function in the absence of TCR signaling 34, 35 . Such results might appear to be at odds with the published finding that a transgene encoding STAT5b-CA driven by the proximal Lck promoter and Eµ enhancer fails to curtail fatal lymphoproliferative disease in Il2rb −/− mice despite restoring Foxp3 expression and T reg cell differentiation in the thymus 9 . However, the interpretation of the last result is problematic due to the massive population expansion of pre-leukemic T cells and B cells and reduced expression of the STAT5b-CA-encoding transgene in peripheral T reg cells.
Our studies have demonstrated that depriving T eff cells of IL-2 by T reg cells was fully dispensable for the suppression of IL-2R-sufficient CD4 + T cells, even though IL-2R signaling was required. However, IL-2R-dependent consumption of IL-2 by T reg cells was indispensable for the suppression of CD8 + T cell responses. The last, seemingly unexpected finding makes sense given the observed exquisite sensitivity of both naive CD8 + T cells and activated CD8 + T cells to IL-2-induced stimulation. Furthermore, IL-2 is produced upon activation of both naive CD4 + T cells and CD8 + T cells within hours of TCR engagement, in contrast to the production of effector cytokines such as IL-4 and IFN-γ, which requires the differentiation of naive T cells into T eff cells on a much longer time scale 41 . Such distinguishing features provide a likely explanation for the need for a distinct mechanism for the control of CD8 + T cell responses by T reg cells through IL-2 consumption.
It has been suggested that sensing of local IL-2 production by T reg cells enables 'licensing' of their suppressor function 21 . However, the 'rescue' of the suppression of CD4 + T cell responses by IL-2R-deficient T reg cells expressing an active form of STAT5 suggested that activated T reg cells can suppress autoimmunity without identifying the cellular source of IL-2. Thus, while IL-2 is a booster for the suppressor function of T reg cells, it might not have an indispensable role as a cue for specific targeting.
Genetically modified T cells are emerging as a potent means of therapy in some forms of cancer. The observed enhanced suppressor activity of T reg cells expressing an active form of STAT5 and significantly reduced severity of organ-specific autoimmunity in their presence would suggest that such modification of T reg cells might hold promise for the optimal design of T reg cell-based therapies for a variety of autoimmune and inflammatory disorders and organ transplantation.
Our findings have highlighted a central role for IL-2R-signalingdriven activation of STAT5 in supporting and boosting the suppressor function of differentiated T reg cells. In this context, it is noteworthy that although a Foxp3 ortholog has not been identified in birds, CD4 + T cell subsets with high expression of IL-2Rα have in vitro suppressor activity in chicken and ducks 42, 43 . This suggests the importance of evolutionary conservation of IL-2Rα function in suppressive T cells.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. GEO: microarray data, GSE84553. 
